Try our beta test site

Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Inovio Pharmaceuticals
Walter Reed Army Institute of Research (WRAIR)
Information provided by (Responsible Party):
GeneOne Life Science, Inc.
ClinicalTrials.gov Identifier:
NCT02670187
First received: January 27, 2016
Last updated: July 26, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)